Displaying items by tag: uab medicine

O’Neal Comprehensive Cancer Center at UAB is among three groups selected nationwide for the Co-Creating Solutions to Address Racism and Disparities in Oncology initiative coordinated by the Center for Health Care Strategies.
Blood shortages are common in the summer months, and COVID-19 has played havoc with usual donation patterns.
In October 2020, amid a global pandemic, the UAB Comprehensive Transplant Institute launched the Southeast’s first uterus transplant program — only the fourth of its kind in the United States.
The Endospan TRIOMPHE study will enroll patients at up to 30 centers in the United States to evaluate the safety and effectiveness of the NEXUS™ aortic arch stent graft system.
To date, 43 percent of vaccine doses administered by UAB have gone to underrepresented communities, with almost 30 percent to Black Alabamians.
Heart failure is a leading cause of death in the United States. Highly effective medications are now available, and the disease is manageable if patients seek care and take their prescribed medications regularly.
Following a more than 40 year career as a senior leader in healthcare, Will Ferniany, CEO of the UAB Health System and the UAB/Ascension St. Vincent's Alliance, will retire at the end of year.
UAB’s Women & Infants Center is recognized for efforts to prevent sudden unexpected infant death.
Masking can prevent more than COVID-19 from spreading this spring: Allergic rhinitis symptoms have shown to be significantly reduced with facemask usage during the pandemic.
Friday, March 19, will be celebrated as “Birmingham Healthcare Heroes Day” by hospitals throughout the Birmingham community.
UAB vaccine demographic numbers holding steady as Center Point vaccination site preps for Friday, March 19, opening.
After a pause due to COVID-19, UAB has resumed enrollment for the All of Us Research Project.
A UAB nurse was the only resource for sharing what life was like inside the COVID-19 Intensive Care Unit at UAB Hospital.
Proton International at UAB reached significant milestones in its first year. More than 5,000 treatments have been performed, with most patients getting 30-35 treatments. Some 142 patients have completed therapy.
Gift from the Altec / Styslinger Foundation acted as catalyst for the Altec / Styslinger Genomic Medicine and Data Sciences Building, which is set to have worldwide impact.
American Cancer Society Emergency Lodging grants focus on addressing unmet lodging needs of cancer patients, particularly vulnerable populations experiencing an unequal burden of cancer.
Page 13 of 50